McKesson 2016 Annual Report Download - page 12

McKESSON CORPORATION
• McKesson Sponsored Clinical Services (SCS) Network — Access to patient-support services that
allow pharmacists to earn service fees and to develop stronger patient relationships.
Institutional Healthcare Providers — Electronic ordering/purchasing and supply chain management systems
that help customers improve financial performance, increase operational efficiencies and deliver better patient
care. Solutions include:
• Fulfill-RxSM — Ordering and inventory management system that empowers hospitals to optimize the
often complicated and disjointed processes related to unit-based cabinet replenishment and inventory
management.
• Asset Management — Award-winning inventory optimization and purchasing management program
that helps institutional providers lower costs while ensuring product availability.
• SKY Packaging — Blister-format packaging containing the most widely prescribed dosages and
strengths in generic oral-solid medications. SKY Packaging enables acute care, long-term care and
institutional pharmacies to provide cost-effective, uniform packaging.
• McKesson Plasma and BioLogics — A full portfolio of plasma-derivatives and biologic products.
• McKesson OneStop Generics®— Described above.
McKesson Specialty Health (“MSH”): This business provides a range of solutions to oncology and other
specialty practices operating in communities across the country, to pharmaceutical and biotechnology suppliers
who manufacture specialty drugs and vaccines, and to payers and hospitals. MSH is focused on three core
business lines: Manufacturer Solutions, Practice Management and Provider Solutions.
Manufacturer Solutions help manufacturers accelerate the approval and successful commercialization of
specialty pharmaceuticals across the product life cycle. MSH’s offerings include supply chain services, including
specialty pharmacy services and third party logistics (“3PL”), provider and patient engagement programs,
clinical trial support, patient assistance programs, reimbursement services, and analytics. In addition, MSH helps
manufacturers minimize reimbursement challenges while offering affordable, safe access to therapies through
Risk Evaluation and Mitigation Strategies (“REMS”) programs.
In April 2016, we completed the acquisition of Biologics, Inc (“Biologics”), a Cary, North Carolina-based
company that provides oncology pharmacy services to providers and patients as well as solutions for
manufacturers and payers. For manufacturers, Biologics helps optimize speed-to-therapy, enhance patient
adherence and improve patient access to therapy. In addition, Biologics works with manufacturers to develop
custom strategies to enhance the clinical and commercial success of their products at each stage of the life-cycle.
Practice Management provides a variety of solutions, including practice operations, healthcare information
technology, revenue cycle management and managed care contracting solutions, evidence-based guidelines and
quality measurements to support The U.S. Oncology Network, one of the nation’s largest network of integrated,
community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. We also
support U.S. Oncology Research, one of the nation’s largest research networks, specializing in oncology clinical
trials.
In April 2016, we also completed the acquisition of Vantage Oncology Holdings LLC (“Vantage”), a
leading national provider of integrated oncology and radiation services headquartered in Manhattan Beach,
California. Vantage’s comprehensive oncology management services model, including its focus on community-
based radiation oncology, medical oncology, and other integrated cancer care services, complements and
strengthens the existing offerings of McKesson and The US Oncology Network, while allowing patients to
access the care they need in an efficient and cost effective way.
6